Archives: Courses
#82 Laboratory Medicine Series Part-4 (Assessment Part-10)
Laboratory medicine is a cornerstone of proper diagnosis and patient safety. This series is designed to break down the commonly used laboratory investigations in naturopathic and functional medicine. It will describe the tests in each category, discuss their meaning and define next steps to follow when abnormalities are found.
#81 Lab Assessment Part-3 GI Lab Considerations
Laboratory medicine is a cornerstone of proper diagnosis and patient safety. This series is designed to break down the commonly used laboratory investigations in naturopathic and functional medicine. It will describe the tests in each category, discuss their meaning and define next steps to follow when abnormalities are found.
#80 Laboratory Assessment Part-2
In this webinar DrA will continue the lab assessment topics requested by subscribers. Our focus for this webinar will be pancreatic assessment, blood sugar assessment and “metabolic markers”.
#79 Laboratory Medicine Series: Part-1
Laboratory medicine is a cornerstone of proper diagnosis and patient safety. This series is designed to break down the commonly used laboratory investigations in naturopathic and functional medicine. It will describe the tests in each category, discuss their meaning and define next steps to follow when abnormalities are found.
#78 LDN Updates and Dosing Information
Since the publication of the data regarding cyclic dosing from St. George’s University by Liu, et. al in 2016 the question of continuous dosing of LDN versus cyclic dosing has been posed. In this presentation Dr. Anderson will discuss the cell and tumor biology – pharmacology interface where this idea comes from and develop the …
#77 Cases in Neurochemistry
Neurochemistry is accessed daily in medicine by commonly used neuropsychiatric drug classes. In natural and integrative medicine, it is often confusing where to start with cases involving neurotransmitters and other factors due to overlap of signs and symptoms, concomitant medication use, and other issues. In this webinar Dr. Anderson will use his experience in thousands …
#76 Blood-Brain and GI Barrier Connection:
The barrier functions of the GI tract and the Brain were long thought to be separate. Modern research has not only shown a connection but an interdependence between these two critical systems. This presentation will look at the recent science showing these connections and discuss the clinical importance of repair of the systems in the …
#75 Immunology Part 5 Functional Immunology and Updates on TH1/2/17 Balance
Immunology is an ever-emerging part of biomedical science. In this session Dr. Anderson will update attendees regarding the Cell Mediated immune response, specifically where it concerns TH-1 and TH-2 effects, and their related immunology. The interrelationships between this portion of CMI and clinical medicine will be discussed.
#74 PharmPart-23 Vitamin C Use: Pharmacology, Safety, & Clinical Tips Q&A Part 2
The use of Vitamin C in integrative and Naturopathic medicine has a long history. The increase in use of newer forms such as liposomal oral products and wider use of IV Vitamin C has sparked a new group of clinical questions, safety and administration guidelines and general mechanism conundrums. This second installment CE is a …
#74 PharmPart-23 Vitamin C Use: Pharmacology, Safety, & Clinical Tips Q&A Part 2 Read More »
#73 Vitamin-C: Clinical Q&A Part-1
The use of Vitamin C in integrative and Naturopathic medicine has a long history. The increase in use of newer forms such as liposomal oral products and wider use of IV Vitamin C has sparked a new group of clinical questions, safety and administration guidelines and general mechanism conundrums. This CE is a merger of …
#72 – Biological Medicines
#72 – Biological Medicines: Clinical Tips, Considerations, and Integrations with natural medicines. Targeted biological therapies have in one way revolutionized some chronic GI diseases. In other ways they have complicated the landscape, monitoring and management of the GI patient. The positive and negative aspects of these therapies will be discussed. Common drugs, adverse events and …
Basic Science Boards
NPLEX Review Series Basic Science Review Overview The current format includes a twenty-plus module series of presentations arranged in a case / organ / complaint format based on the clinical science format used by NABNE / NPLEX. Information based on learning content areas and seventeen years teaching and writing board exam questions will be given …
Clinical Science Boards
NPLEX Review Series Clinical Science Review Overview The current format includes a twenty-plus module series of presentations arranged in a case / organ / complaint format based on the clinical science format used by NABNE / NPLEX. For each complaint / body system (Cardio, Neurology…) area the following topic areas will be focused on: Clinical …
#71 Post COVID Syndrome
2.0 Hours Total / 1.0 Hours Pharmacology #71 Post COVID Syndrome Post-COVID syndrome affects a portion of patients who have had COVID-19. The random nature of the signs and symptoms and their intensity are perplexing to clinicians trying to help these patients. In this CME Dr. Anderson will break down data from over 1000 patients …
#70 Toxins, Immune Function, and Cancer
#70 Toxins, Immune Function, and Cancer Outline: Risk factors for cancer and proposed mechanisms:Metal toxinsChemical toxinsMycotoxins Testing and assessment: Therapeutic Strategies:In the preventive settingIn the “secondary prevention” setting treating after cancer care to preventrecurrence Got a question? Head to the forum! Every Webinar has an associated, private forum. If you have a question, head there …
#69 Injection Update IM and SQ
#69 Injection Update IM and SQ In this session Dr. Anderson will use his many decades injection experience to discuss customizing parenteral nutrient combinations and specific dosages for maximum efficacy. While this presentation will cover the pharmacology and administration of Vitamin, Mineral and Amino Acids it may also include appropriate drug agents. IV and IM …
#64 PHARM Part-20 Repurposed Drugs in Oncology
#64 PHARM Part-20 Repurposed Drugs in Oncology Antibiotics, Anti-parasite and other drugs in cancer care? These seem to be making a lot of waves in oncology these days. Dr. Anderson will outline the data for and use of the primary off-label drug strategies as well as his experience with them. He will also look at …
#68 GI Part-2 GI Function and Therapeutics
#68 GI Part-2 GI Function and Therapeutics The gastrointestinal tract is often considered to be of paramount importance in long term health and disease prevention. “Treat the gut first” is common advice given and for good reason. In this CE Dr. Anderson will contrast normal GI function with how that function breaks down and the …
#62 COVID-19 Part-1 Clinician Updates
#62 COVID-19 Part-1 Clinician Updates With the urgent and changing landscape off the COVID-19 Pandemic several urgent needs arise for healthcare providers in the area of patient management. While this CE is NOT meant to re-hash the “known” factors such as social isolation, quarantine, hand washing etc. it IS designed to look at potential needs …
#61 Assessment Part-5 Red Flags and Critical Diagnosis Management
#61 Assessment Part-5 Red Flags and Critical Diagnosis Management In both the chronic and acute care setting the presentation of concerning clinical signs and symptoms can create a diagnostic and management quandary. If ongoing the presentation may simply need to be watched and monitored, if new or exacerbated the presentation may require acute work up …
#61 Assessment Part-5 Red Flags and Critical Diagnosis Management Read More »
#67 Immunology Part-4 Natural Immunologic Agents
#67 Immunology Part-4 Natural Immunologic Agents The plethora of new data regarding some natural immunologic agents is seemingly never ending. In this course we will specifically look at current data, testing and assessment and clinical factors in the use of common immunologic natural agents.
#66 Controversies in Oncology
#66 Controversies in Oncology Controversies (or maybe not) in Integrative Oncology: We hear “sound bites” saying ‘DON’T USE THIS IN CANCER PATIENTS’, or ‘THIS IS DANGEROUS’ etc. and are often confused. It becomes more confusing when the ‘experts’ will not all agree, and the treating physician is often not in a position to delve deeply …
#65 Immunology Part-3 Immunology Clinician Update
#65 Immunology Part-3 Immunology Clinician Update Immunology is one of the most rapidly changing disciplines in clinical medicine. In this CME Dr. Anderson will break down the commonly understood processes in the human immune response and how those relate to factors such as cytokines and chemokines, growth factors and other immunobiology. Where appropriate immunological crossover …
#65 Immunology Part-3 Immunology Clinician Update Read More »
#63 Assessment Part-6 Managing Comorbidity in Chronic Cases
#63 Assessment Part-6 Managing Comorbidity in Chronic Cases The chronically ill patient is difficult to manage considering their primary concerns regardless of cause. And while they often have infectious, hormonal, GI, toxic or many other underlying conditions to manage it is often the “transitory symptoms” that create the biggest clinical management troubles. In this webinar …
#63 Assessment Part-6 Managing Comorbidity in Chronic Cases Read More »
#60 PHARM Part-19 Advanced Adrenal Assessment and Therapeutics
#60 PHARM Part-19 Advanced Adrenal Assessment and Therapeutics Adrenal gland function is complex and often underrated in medicine as to its role in overall health. This is even more a problem in the chronically ill patient. In this presentation we will look at the assessment of adrenal function, how the function can be affected by …
#60 PHARM Part-19 Advanced Adrenal Assessment and Therapeutics Read More »
#43 Lab Testing for Vitamins B6, B12, and Folates
#43 Lab Testing for Vitamins B6, B12, and Folates Key concepts of Lab Testing for Vitamins B6, B12 and Folates are discussed in this webinar with Dr. Anderson.
#44 PHARM Part-15 Acute Use of Thyroid and Adrenal-RX
#44 PHARM Part-15 Acute Use of Thyroid and Adrenal-RX Key concepts of “Thyroid and Adrenal Therapies in the Acute or Chronic Illness Setting: Pharmacology, Management and Suppression” are discussed in this webinar with Dr. Anderson.
#46 Respiratory Pharmacology Part-2 Natural Therapies Nebulizer and others
#46 Respiratory Pharmacology Part-2 Natural Therapies Nebulizer and others Key concepts of “Nasal and Lower Respiratory Therapeutics” are discussed in this webinar with Dr. Anderson
#47 2019 USP-FDA Compounding Update
#47 USP-FDA Compounding Update USP 797> in process for 2019-2020. What are the risk levels for in office compounding. What do you need to do in your office for compliance. What if you are inspected. How do you make your equipment, processes and procedures compliant. In office compounding, office use drugs, cleanroom and other compliance. …
#45 Assessment Part-2 Naturopoathic and Integrative Thought for the 21st Century
#45 Assessment Part-2 Naturopoathic and Integrative Thought for the 21st Century Key concepts of “Optimizing 21st Century Naturopathic and Integrative Medicine” are discussed in this webinar with Dr. Anderson.
#42 PHARM Part-14 NAD Therapies
#42 PHARM Part-14 NAD Therapies Key concepts of NAD are discussed in this webinar with Dr. Anderson.
#28 Immunology Part-1 Low Dose Naltrexone
#28 Immunology Part-1 Low Dose Naltrexone Overview: Basic pharmacology of Naltrexone Low versus High Dose Strategies Low Dose Mechanisms Clinical Uses Prescribing Guidelines Resources
#29 PHARM Part-12 Medical Cannabinoids Pharmacology and Clinical Use
#29 PHARM Part-12 Medical Cannabinoids Pharmacology and Clinical Use Indications, Dosing and Management Topic Outline: What is it? Clinical Pharmacology Clinical uses Practicalities: Dose, Form, Administration Some other resources
#30 NEURO Part-1 Neurological Therapies
#30 NEURO Part-1 Neurological Therapies Inflammation, Healing and Incorporation of Natural Therapies Topic Outline: 1.) Key concepts in functiono Nutrition – Cell Support – Neurotransmission – Balance 2.) Primary pathogenesis – Inflammation – Malnutrition – Imbalance 3.) Treating / correcting imbalance and dysfunction -Inflammation -Malnutrition -Imbalance
#31 Food Allergy and Sensitivity Syndromes
#31 Food Allergy and Sensitivity Syndromes Food Allergy and Sensitivity Syndromes Topic Outline: Immunology Food Allergy and Sensitivity Basics Types of testing Implications of Testing Interventions and Monitoring
#33 Kidney and Liver Functions Lab and Clinical Effects
#33 Kidney and Liver Functions Lab and Clinical Effects Topic Outline: 1.) Liver functions and clinical relevance Mechanisms Medications and supplements Clinical discussion 2.). Kidney function and clinical relevance Mechanisms Medications and supplements Clinical discussion CME Total 1.5 hours – Of that pharmacology CME is 1.5 hours The purchase of this product is designed for …
#33 Kidney and Liver Functions Lab and Clinical Effects Read More »
#34 Organic Acid Testing (OAT) and Interpretation
#34 Organic Acid Testing (OAT) and Interpretation Topic Outline: WHAT ARE ORGANIC ACIDS? HOW ARE ORGANIC ACIDS ASSAYED FOR MEDICAL REASONS? HOW ARE ORGANIC ACIDS TESTS USED FOR PATHOLOGIC IMPORTANCE? INTERPRETATIONS
#35 PHARM Part-13 Migraine Assessment and Treatment
#35 PHARM Part-13 Migraine Assessment and Treatment Overview – Migraine Myths Migraine is neither an “extreme headache” nor a psychosomatic condition, as many patients and some healthcare providers continue to believe. One of the most pervasive misconceptions is that migraine is a vascular disease. Current and emerging evidence disproves this notion and has established that …
#35 PHARM Part-13 Migraine Assessment and Treatment Read More »
#32 HBOT-1 Hyperbaric Oxygen Therapies General
#32 HBOT-1 Hyperbaric Oxygen Therapies General Hyperbaric Oxygen Uses, Pharmacology and Management Topic Outline: What is HBOT Chamber Types / Pressures Prescription Parameters Neurological Considerations Oncology
#39 NEURO Part-2 Dysautonomia and EDS
#39 NEURO Part-2 Dysautonomia and EDS Key concepts in Dysautonomia and EDS discussed in this webinar with Dr. Anderson.
#40 Immunology Part-2 Low Dose Immunotherapy (LDI)
#40 Immunology Part-2 Low Dose Immunotherapy (LDI) Key concepts in Low Dose Immunotherapy are discussed in this webinar with Dr. Anderson.
#36 PCOS
#36 PCOS PCOS – Assessment and Treatment Considerations Dr. Anderson discusses the PCOS, the history, and latest developments, as well as clinical observations.
#37 Detoxification Part-2 Fluoroquinolone Toxicity
#37 Detoxification Part-2 Fluoroquinolone Toxicity Treatment Considerations Fluoroquinolones (FQs) are among the most potent antimicrobial agents, which have seen their increasing use as human and veterinary medicines to control bacterial infections. FQs have been extensively found in surface water and municipal wastewaters, which has raised great concerns due to their negative impacts to humans and …
#37 Detoxification Part-2 Fluoroquinolone Toxicity Read More »
#38 GI Part-1 Nutrient Absorption and GI Health
#38 GI Part-1 Nutrient Absorption and GI Health Key concepts in GI function discussed in this webinar with Dr. Anderson.
#41 Detoxification Part-3 Detox of Unusual Metals
#41 Detoxification Part-3 Detox of Unusual Metals Key concepts in Detox of Unusual Metals are discussed in this webinar with Dr. Anderson.
#25 IV Injection Q&A Part-2
#25 IV Injection Q&A Part-2 An update regarding injection therapies, how the newer rules for compounding change things and time for questions. Part-1: Rules for compounding and handling Part-2: Injection therapy updates and clinical thinking
#26 PHARM Part-10 ADHD Medication Pharmacology and Weaning
#10 PHARM Part-10 ADHD Medication Pharmacology and Weaning ADHD Medication: Pharmacology and Weaning ADHD Diagnosis and Cause theories ADHD Pharmacology ADHD Therapeutic approaches
#27 PHARM Part-11 Seizure (Epilepsy) Medication Pharmacology and Weaning
Subtitle Goes Here #XX Webinar Title Goes Here Ever wonder what goes on in Dr. A’s head?… Maybe not – but one of the most common questions he gets is “How can I figure out how bad off the patient is and where to start – then when the case changes how do I do …
#27 PHARM Part-11 Seizure (Epilepsy) Medication Pharmacology and Weaning Read More »
#24 Nutrigenomic Basics with Q&A
#24 Nutrigenomic Basics with Q&A A basic approach to nutrigenomics, how epigenetics interact and how to navigate treatment with patients.
#22 PHARM Part-9 Chronic Pain Medication Weaning
#22 PHARM Part-9 Chronic Pain Medication Weaning In this webinar, Dr. Anderson will discuss the basics of pain medication pharmacology and weaning from those medications. Assessment Therapy Management
#23 Assessment Part-1 Chronic Cases Review and Clinical Thinking
#23 Assessment Part-1 Chronic Cases Review and Clinical Thinking Modern chronic illness is more complex and difficult to assess and treat than ever before. Aggravating factors such as infectious and immune effect, genomic variations, toxicants and others make the chronically ill patient complex. This session is designed to list the research behind these crossover points …
#23 Assessment Part-1 Chronic Cases Review and Clinical Thinking Read More »
#18 Autoimmunity Part-2 Case Management
#18 Autoimmunity Part-2 Case Management This webinar is a follow up to “Autoimmunity Part-1” expanding on cause areas and therapeutic options.
#17 PHARM Part-8 Respiratory Pharmacology Part-1 Prescription Management
#17 PHARM Part-8 Respiratory Pharmacology Part-1 Prescription Management In this webcall Dr. Anderson will describe the clinically relevant issues surrounding the choice of, dosing for and tapering off of steroid medications (including respiratory medications). How best to do it? How to use natural medications in the process? Case examples and Q&A included.
#16 PHARM Part-7 Blood Pressure and Cardiac Pharmacology and Management
#16 PHARM Part-7 Blood Pressure and Cardiac Pharmacology and Management Ever wonder what goes on in Dr. Au2019s head?u2026 Maybe not u2013 but one of the most common questions he gets is u201cHow can I figure out how bad off the patient is and where to start u2013 then when the case changes how do …
#16 PHARM Part-7 Blood Pressure and Cardiac Pharmacology and Management Read More »
#15 PHARM Part-6 Kidney Disease Management and Pharmacology
#15 PHARM Part-6 Kidney Disease Management and Pharmacology PHARM Part-4 Antidepressant Pharmacology and Tapering
#14 Biofilm Pathology Assessment and Management
Therapeutics #14 Biofilm Pathology Assessment and Management Biofilms – Concepts and Therapies In this special WebCall Dr. Anderson will review the latest science and clinical outcomes from years of clinical research in biofilm therapies. He will outline the difference between Phase-1 and Phase-2 biofilms, and how to assess and treat each part of that spectrum. …
#13 PHARM Part-5 Pediatric Dosing Strategies
Therapeutics, Organ System #13 PHARM Part-5 Pediatric Dosing Strategies In this webcall Dr. Anderson will describe the clinically relevant issues surrounding dose adjustments for pediatric patients. Calculation strategies, what matters most and clinical examples of Oral, IV and Injection therapies will be discussed.
#12 PHARM Part-4 Antidepressant Pharmacology
Therapeutics, Clinical Thinking #12 PHARM Part-4 Antidepressant Pharmacology and Tapering In this webcall Dr. Anderson will describe the clinically relevant issues surrounding the choice of, dosing for and tapering off of antidepressants. We include a discussion of best to taper, how to use natural medications in the process, and a staggering amount of biochemical flow …
#11 Detoxification- Sulfite Toxicity and Sulfation Pathways
Therapeutics, Clinical Thinking #11 Detoxification- Sulfite Toxicity and Sulfation Pathways Ever wonder what goes on in Dr. Au2019s head?u2026 Maybe not u2013 but one of the most common questions he gets is u201cHow can I figure out how bad off the patient is and where to start u2013 then when the case changes how do …
#11 Detoxification- Sulfite Toxicity and Sulfation Pathways Read More »
#10 IV Injection Q&A Part-1
Therapeutics, Clinical Thinking #10 IV Injection Q&A Part-1 Questions include: What is causing delayed onset fever, malaise and chills after an IV? Do we need special tubing for ALA? GSH protocol for skin lightening? Comments on Dr. Berkson’s ALA protocol and how to decide which IV protocol to give for cancer patients? An explanation and …
#09 ReDox and Inflammation Cell Damage and Therapies
Organ Systems, Therapeutics #09 ReDox and Inflammation Cell Damage and Therapies Ever wonder what goes on in Dr. Au2019s head?u2026 Maybe not u2013 but one of the most common questions he gets is u201cHow can I figure out how bad off the patient is and where to start u2013 then when the case changes how …
#09 ReDox and Inflammation Cell Damage and Therapies Read More »
#08 Mitochondria: Function Damage and Repair
Organ Systems, Therapeutics #08 Mitochondria: Function Damage and Repair This is a broad discussion of mitochondrial damage and how it is involved in the pathology of most chronically ill. We review mitochondrial function, cofactors, and a bunch of nice nerdy papers on how natural substances can promote repair of damaged tissues by restoring mitochondrial function. …
#07 Histamine Triggers MCAS and Therapies
Organ Systems, Therapeutics #07 Histamine Triggers MCAS and Therapies This webcall will focus differently from the prior one on histamine in June, as it concentrates on peripheral histamine metabolism in atopy, allergy and like conditions. We review HIS in the CNS, including neurotransmitter balance and metabolism then move to catecholamine metabolism, methylation and interactions with …
#06 Autoimmunity Part-1 Overview and Case Assessment
Organ Systems, Therapeutics #06 Autoimmunity Part-1 Overview and Case Assessment We start off with general thoughts in AI about assessing “cause” from allergy to toxicity, then move on to laboratory assessment and do an extensive discussion of the best therapeutics and treatment plans encompassing endocrine, chronic infection, snps, GI health, IV therapies etc. We include …
#06 Autoimmunity Part-1 Overview and Case Assessment Read More »
#05 PHARM Part-3 Dessicated Thyroid Rx Management
Organ Systems, Therapeutics #05 PHARM Part-3 Dessicated Thyroid Rx Management The use of desiccated thyroid (DT)has a long history, but the medication has been less prescribed than synthetic forms for decades. This webcall will discuss the assessment, prescribing and re-assessment of this useful medication. Dr. Anderson has been using desiccated thyroid in practice for decades. …
#05 PHARM Part-3 Dessicated Thyroid Rx Management Read More »
#04 PHARM Part-2 T3 and Iodine Rx & Safe Dosing
Organ Systems, Therapeutics #04 PHARM Part-2 T3 and Iodine Rx & Safe Dosing This Webcall includes a comprehensive discussion of iodine and T3 therapies. We touch on the best way to test Iodine levels, go over iodine toxicity symptoms, and bromide detox and how to best manage it as well as iodine cofactors and metallotoxins. …
#03 PHARM Part-1 Cortisol and Adrenal Therapies
Organ Systems, Therapeutics #03 PHARM Part-1 Cortisol and Adrenal Therapies This is a discussion of the latest information about the safe use of cortisol, glandulars and other adrenal therapies. Testing, dosing and follow up are discussed. We review adrenal function, and talk about how to address functional illnesses (adrenal fatigue) in order to stop progression …
#02 Neuroinflammation, Histamine and other Inflammatory Mediators
#02 Neuroinflammation, Histamine and other Inflammatory Mediators “This webinar discusses histamine actions in the body, peripherally and in CNS. Histamine metabolism, elimination pathways and necessary nutrients for optimal pathway function. Methylation and histamine, interactions between Glutamate and histamine and leaky gut and leaky Blood Brain Barrier BBB and immunologic mediated inflammation. Chronic infections, mitochondrial support …
#02 Neuroinflammation, Histamine and other Inflammatory Mediators Read More »
#01 05.15 EBV Diagnosis, Treatment, and Management
EBV Diagnosis This course discussed the appropriate diagnosis and treatment of EBV. It includes lab testing, patient assessment, comorbidity and global treatment with prescription and natural medicines. Got a question? Head to the forum! Every Webinar has an associated, private forum. If you have a question, head there and ask. Go To Forum (Beta)
#21 Detoxification Part-1 Oral Chelation
#21 Detoxification Part-1 Oral Chelation Oral Chelation – Assessment, Treatment, and Safety in the use of oral chelation substances. This webinar looks at the latest ideas in heavy metal assessment, dosing and synergy of oral chelation substances and how to safely perform oral chelation in any situation. How to support the patients’ physiology and cause …
#19 Chronic Infections Part-1 Assessment and Reassessment
#19 Chronic Infections Part-1 Assessment and Reassessment In this webinar Dr. Anderson will discuss the various levels of assessment and management in the chronically infected patient. The focus will be mainly on assessment and management of this complex category of human illness and will closely be followed next month by the webinar: “Lyme Disease – …
#19 Chronic Infections Part-1 Assessment and Reassessment Read More »
#20 Chronic Infections Part-2 Infectious Agents Lyme and Others
#20 Chronic Infections Part-2 Infectious Agents Lyme and Others n this webinar, Dr. Anderson will discuss Lyme Disease: A top-down approach In the last webinar, we discussed the various levels of assessment and management in the chronically infected patient. The focus was mainly on assessment and management of this complex category of human illness, and …
#20 Chronic Infections Part-2 Infectious Agents Lyme and Others Read More »
#59 Detoxification Part-4 Metabolic Toxins
#59 Detoxification Part-4 Metabolic Toxins Sulfites, Oxalates, Pyrroles, Salicylates, Aldehydes, Alcohols, & Related Compounds. The implications for human health when dealing with metabolic toxins are many and far reaching. Sulfates, Oxalates, Pyrroles, Salicylates, Aldehydes, Alcohols and related compounds. Each can arise as a health issue from direct exposure, metabolism of other substances, diseases, genomic pathway …
#58 Chronic Infections Part-4 Natural Agent Management
#58 Chronic Infections Part-4 Natural Agent Management In this webinar Dr. Anderson will outline the use of natural medicines in chronic infectious cases. Botanical and other agents will be discussed as will pharmacology, dosing, potential toxicity and other safety issues. AANP CME 2 hours / 2 of which are Pharmacology
#57 PHARM Part-18 Strong Botanicals (“Low Dose,” “Toxic,” “Eclectic,” etc.) Pharmacology Dosing Clinical Use Safety
#57 PHARM Part-18 Strong Botanicals (“Low Dose,” “Toxic,” “Eclectic,” etc.) Pharmacology Dosing Clinical Use Safety In this webinar we will look at the safe and effective use of herbal medications most people only know historically. These herbs were used quite effectively in the historical traditions of American herbalists, the “Eclectic” Physicians and many others. In …
#56 Chronic Infections Part-3 Pharmaceutical Agent Management
#56 Chronic Infections Part-3 Pharmaceutical Agent Management In this webinar Dr. Anderson will Cover the difference between acute and chronic dosing for anti viral, parasite, bacterial, helmithic, and related medications. Use of Biofilm agents and timing of such will be discussed. Why your pharmacist may not understand and how to deal with that as well …
#56 Chronic Infections Part-3 Pharmaceutical Agent Management Read More »
#55 PHARM Part-17 Benzodiazepines Pharmacology Prescribing Tapering and Management
#55 PHARM Part-17 Benzodiazepines Pharmacology Prescribing Tapering and Management Benzodiazepines – Prescribing, monitoring and tapering. In this session Dr. Anderson will discuss the most common classes of anxiety and sleep medications in the benzodiazepine class. Their pharmacology and prescribing will be contrasted with their effects on the human brain. Crossovers with nutritional substances and effective …
#55 PHARM Part-17 Benzodiazepines Pharmacology Prescribing Tapering and Management Read More »
#54 NEURO Part-5 Neurological Manifestations in Chronic patients – Assessments and Management
#54 NEURO Part-5 Neurological Manifestations in Chronic patients – Assessments and Management Although a chronic illness may not seem to be happening in the body many patients have neurological manifestations which can be both surprising as well as difficult to find and treat. These can be cancer, chronic infections, mold illness, toxicity and others. In …
#53 Assessment Part-4 Interrelationships in Chronic Disease
#53 Assessment Part-4 Interrelationships in Chronic Disease Is it true that cancer, infections, autoimmunity and environmental disruptors all “feed on” each other? What does the science really say? If so how do we fit this into our thought process with patients? How does this inform: Prevention? Treatment? Assessment?